Epizyme reported $312.19M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbott ABT:US $ 74007M 1189M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Amarin AMRN:US $ 973.71M 94.36M
Amgen AMGN:US $ 59196M 1969M
Avrobio Inc AVRO:US $ 175.34M 28.49M
Biogen BIIB:US $ 23614.4M 262.9M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Daiichi Sankyo 4568:JP Y 2221402M 57930M
Eisai 4523:JP Y 1239315M 71959M
Epizyme EPZM:US $ 312.19M 23.19M
Exelixis EXEL:US $ 2654.12M 37.88M
Gilead Sciences GILD:US $ 63080M 4872M
GlaxoSmithKline GSK:LN 89689M 10586M
Glaxosmithkline GSK:US $ 89689M 10586M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Macrogenics MGNX:US $ 271.44M 63.8M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Novartis NOVN:VX SF 125218M 6577M
Novartis NVS:US $ 125218M 6577M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Spectrum Pharmaceuticals SPPI:US $ 100.05M 11.49M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Xencor XNCR:US $ 857.92M 19.71M